Featured Image for POP Biotechnologies
POP Biotechnologies' SNAP Vaccine System Safe and Effective in a Phase II Clinical Trial for COVID-19
November 30, 2022 15:01 ET | POP Biotechnologies
BUFFALO, N.Y., Nov. 30, 2022 (GLOBE NEWSWIRE) -- POP Biotechnologies (POP BIO), a Buffalo, New York-based biopharmaceutical startup, announces the publication of an interim analysis of the Phase 2...
GOVX.jpg
GeoVax to Present at Vaccines Summit-2022
October 11, 2022 09:00 ET | GeoVax, Inc.
Presentation to Focus on Development of Pan-Coronavirus (Universal) Vaccines to Protect Against Evolving Variants ATLANTA, GA, Oct. 11, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc....
EuCorVac-19
POP Biotechnologies' SNAP Vaccine Platform Enters Large-Scale Phase III Clinical Trials for COVID-19
September 20, 2022 21:31 ET | POP Biotechnologies, Inc.
BUFFALO, N.Y., Sept. 20, 2022 (GLOBE NEWSWIRE) -- POP Biotechnologies (POP BIO), a Buffalo, New York-based biopharmaceutical startup, announces the commencement of two Phase 3 clinical studies of...
We Can Do This logo
Diaper banks, We Can Do This campaign team to protect kids as young as 6 months from COVID-19
July 06, 2022 13:34 ET | National Diaper Bank Network
New Haven, July 06, 2022 (GLOBE NEWSWIRE) -- U.S. Department of Health and Human Services (HHS) Secretary Xavier Becerra; Rep. Rosa DeLauro, who represents Connecticut’s 3rd Congressional District;...
GOVX new logo.png
GeoVax to Present COVID-19 Vaccine Data at the Vaccine Summit Boston 2022
March 21, 2022 09:00 ET | GeoVax, Inc.
Presentation to Focus on GEO-CM02 Being Developed as aUniversal Vaccine to Address Evolving SARS-CoV-2 Variants ATLANTA, GA, March 21, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs,...
GOVX new logo.png
GeoVax Retains CATO SMS to Manage Two Phase 2 COVID-19 Vaccine Clinical Trials
March 14, 2022 09:00 ET | GeoVax, Inc.
Comparative Trial Against Pfizer/BioNTech Vaccine Among Immunocompromised PatientsBooster to Pfizer/BioNTech or Moderna Vaccines Among Healthy PatientsATLANTA, GA, March 14, 2022 (GLOBE NEWSWIRE) --...
EuCorVac-19
POP Biotechnologies Vaccine Technology to Enter Phase III Clinical Studies as Part of Eubiologics' COVID-19 Vaccine Candidate, EuCorVac-19
February 06, 2022 22:18 ET | POP Biotechnologies, Inc.
BUFFALO, N.Y., Feb. 06, 2022 (GLOBE NEWSWIRE) -- POP Biotechnologies (POP BIO), a biopharmaceutical startup, announces the approval of the plan for a Phase 3 clinical study of EuCorVac-19, a...
Fifth Update of ACR
Fifth Update of ACR COVID-19 Vaccine Guidance Supports Fourth Doses for High-Risk Rheumatic Disease Patients
February 02, 2022 10:49 ET | American College of Rheumatology
Atlanta, Feb. 02, 2022 (GLOBE NEWSWIRE) -- The American College of Rheumatology has issued an updated version of its COVID-19 Vaccine Clinical Guidance for Patients with Rheumatic and...
Hoarding by Government Continues While Expensive New Medications for Covid Are Unavailable, States the Association of American Physicians and Surgeons (AAPS)
January 17, 2022 13:54 ET | Association of American Physicians and Surgeons
TUCSON, Ariz., Jan. 17, 2022 (GLOBE NEWSWIRE) -- The Association of American Physicians and Surgeons (AAPS) condemns the continued hoarding by the federal government of hydroxychloroquine, which it...
Disaster Called ‘Evidence-Based Medicine’ Exposed in the Journal of American Physicians and Surgeons
December 13, 2021 11:30 ET | Association of American Physicians and Surgeons
TUCSON, Ariz., Dec. 13, 2021 (GLOBE NEWSWIRE) -- The early 1990s movement called “evidence-based medicine” or EBM, full of the noble intention of incorporating high quality research into clinical...